[ MICHAEL J FOX FOUNDATION - Target Advancement Program | Research funding ]
Event details
| Date | 26.09.2018 |
| Category | Call for proposal |
Aim: The Michael J. Fox Foundation believes that a major hurdle in the development of promising treatments for Parkinson's disease (PD) is the need for well-validated targets linked to the disease process. By promoting critical target validation studies within academic and industry laboratories, MJFF investments can help de-risk subsequent drug development and ultimately accelerate the advancement of innovative therapies for Parkinson's patients. The Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.
Target Advancement awards support research characterizing promising, novel PD-relevant targets or continuing target biology work on established PD targets. Preferred targets for this program already demonstrate links to PD in human patient populations. These awards are well-suited to projects in which hypothetical or experimental rationale for a target is compelling but limited, and study results can make the case for continuing (or discontinuing) a line of research. Full details are available in the RFA.
Funding: Maximum USD $150’000
Duration: 12- 18 months
Eligibility: Researchers at all academic levels at or above Assistant Professor are eligible to apply. In addition, Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.
How to Apply: The pre-proposal is the first step in the application. Pre-proposals must be completed in the online application portal. Successful applicants will be given further instructions for submitting a full proposal.
Deadline (Pre-proposal): 26 September 2018 (5:00 pm EST)
Deadline (Full Application, by invitation): 22 January 2019 (5:00 pm EST)
Further information
Target Advancement awards support research characterizing promising, novel PD-relevant targets or continuing target biology work on established PD targets. Preferred targets for this program already demonstrate links to PD in human patient populations. These awards are well-suited to projects in which hypothetical or experimental rationale for a target is compelling but limited, and study results can make the case for continuing (or discontinuing) a line of research. Full details are available in the RFA.
Funding: Maximum USD $150’000
Duration: 12- 18 months
Eligibility: Researchers at all academic levels at or above Assistant Professor are eligible to apply. In addition, Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.
How to Apply: The pre-proposal is the first step in the application. Pre-proposals must be completed in the online application portal. Successful applicants will be given further instructions for submitting a full proposal.
Deadline (Pre-proposal): 26 September 2018 (5:00 pm EST)
Deadline (Full Application, by invitation): 22 January 2019 (5:00 pm EST)
Further information
- See the for more details, or download the
- Find the application portal
- Participate in the MJFF funding opportunities on 06 September to learn more
- For any other questions, contact the Research Office:
Practical information
- General public
- Free